Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunming Kangle Pharmaceutical Co., Ltd. is a long-standing pharmaceutical manufacturer based in Kunming, Yunnan Province, China. Established in 1951, the company specializes in the production of both chemical synthetic drugs and Traditional Chinese Medicine (TCM). Its extensive product portfolio includes various dosage forms such as injections, tablets, and capsules, targeting therapeutic areas like cardiovascular health, respiratory diseases, and pain management. The company operates modern, GMP-certified facilities and is a significant contributor to the regional healthcare industry in Southwest China. Kunming Kangle is recognized for its commitment to quality and its role in providing essential medicines to the domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunming Kang Le.